MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
SPRC SciSparc
- 0.2133
- -0.0004-0.19%
Close Dec 20 16:00 ET
- 0.2190
- +0.0057+2.67%
Post 20:01 ET
2.21MMarket Cap-0.04P/E (TTM)
0.2281High0.2014Low614.39KVolume0.2210Open0.2137Pre Close133.71KTurnover5.93%Turnover RatioLossP/E (Static)10.36MShares6.780052wk High0.29P/B2.21MFloat Cap0.201052wk Low--Dividend TTM10.36MShs Float221.0000Historical High--Div YieldTTM12.49%Amplitude0.0026Historical Low0.2170Avg Price1Lot Size
SciSparc News
SciSparc Announces Spin-Off Plans With Miza III Ventures
SciSparc Provides Updates on Status of Spin-off of Its Advanced Clinical Stage Pharmaceutical Portfolio to a Publicly Traded Company
Express News | Scisparc Provides Updates on Status of Spin-off of Its Advanced Clinical Stage Pharmaceutical Portfolio to a Publicly Traded Company
SciSparc Ltd. to Acquire AutoMax Motors Ltd.
Sector Update: Consumer Stocks Edge Higher Pre-Bell Friday
SciSparc Extends Merger Deadline With AutoMax Motors
Express News | Scisparc Ltd: Right to Terminate Merger Agreement if Merger Was Not Consummated by Nov 30, 2024, Was Deferred to March 31, 2025
Express News | Scisparc Ltd: Entered Into Second Addendum to Merger Agreement With Automax Motors Ltd and Scisparc Merger Sub Ltd
SciSparc Ltd. Reports Changes in Financial Position
SciSparc | 6-K: Report of foreign private issuer (related to financial reporting)
SciSparc Ltd. Gains Shareholder Approval for Proposals
SciSparc Ltd. Reschedules Annual General Meeting
Pharma Company Gets FDA Green Light For Next Phase Trial For Tourette Syndrome
SciSparc Receives FDA Approval To Launch Pivotal Phase IIb Trial For Tourette Syndrome Treatment SCI-110 In U.S., Following Promising Phase IIa Results Showing Up To 40% Tic Reduction
SciSparc Ltd. Proposes Reverse Stock Split
SciSparc: Amitay Weiss Also Serves as Chairman of Bd of Directors of Purchaser >SPRC
SciSparc Will Receive Cash Consideration of $700,000 in Exchange for Shrs That Constitute 27% of MitoCareX Ownership >SPRC
SciSparc: Intended Selling Valuation Represents Increase of 47% From Valuation at Time of Initial Investment in MitoCareX Bio >SPRC
Express News | Scisparc Ltd - Additional Milestones Could Increase Consideration to $7 Mln
Express News | Scisparc Ltd - Owns 52.73% of Mitocarex
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.